New Insights into the Behavior of NHC-Gold Complexes in Cancer Cells
Augello, Giuseppa; Azzolina, Antonina; Rossi, Filomena; Prencipe, Filippo; Mangiatordi, GIUSEPPE FELICE; Saviano, Michele; Ronga, Luisa; Cervello, Melchiorre; Tesauro, Diego
PHARMACEUTICS
IF WOS: NA SJR: 0.892 Best Quartile: Q1
Posizione: 2/9

Hepatocellular Carcinoma: A Difficult Cancer to Treat
Cusimano, Antonella; Soresi, Maurizio; Montalto, Giuseppe; Augello, Giuseppa; Emma, MARIA RITA; Azzolina, Antonina; Cervello, Melchiorre; Giannitrapani, Lydia
CRITICAL REVIEWS IN ONCOGENESIS
IF WOS: NA SJR: NA Best Quartile: NA
Posizione: 6/8

Potential uses of olive oil secoiridoids for the prevention and treatment of cancer: A narrative review of preclinical studies
Emma, Mr; Augello, G; Di Stefano, V; Azzolina, A; Giannitrapani, L; Montalto, G; Cervello, M; Cusimano, A
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
IF WOS: NA SJR: 1.176 Best Quartile: Q1
Posizione: 4/8

The NUPR1/p73 axis contributes to sorafenib resistance in hepatocellular carcinoma
Augello, Giuseppa; Emma, MARIA RITA; Azzolina, Antonina; Puleio, Roberto; Condorelli, Lucia; Cusimano, Antonella; Giannitrapani, Lydia; A McCubrey, James; Lucio Iovanna, Juan; Cervello, Melchiorre
CANCER LETTERS
IF WOS: 9.756 SJR: 1.923 Best Quartile: Q1
Posizione: 3/10

GSK-3 in liver diseases: Friend or foe?
Emma MR; Augello G; Cusimano A; Azzolina A; Montalto G; McCubrey JA; Cervello M;
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
IF WOS: 4.739 SJR: 1.715 Best Quartile: Q2
Posizione: 4/7

Identification of an LPS-Induced Chemo-Attractive Peptide from Ciona robusta
Longo, Valeria; Longo, Alessandra; Martorana, Annamaria; Lauria, Antonino; Augello, Giuseppa; Azzolina, Antonina; Cervello, Melchiorre; Colombo, Paolo
MARINE DRUGS
IF WOS: NA SJR: 0.848 Best Quartile: Q2
Posizione: 6/8

The Role of GSK-3 in Cancer Immunotherapy: GSK-3 Inhibitors as a New Frontier in Cancer Treatment
Augello G; Emma MR; Cusimano A; Azzolina A; Montalto G; McCubrey JA; Cervello M;
CELLS
IF WOS: NA SJR: 1.22 Best Quartile: Q1
Posizione: 4/7

RAS/RAF/MEK/ERK, PI3K/PTEN/AKT/mTORC1 and TP53 pathways and regulatory miRs as therapeutic targets in hepatocellular carcinoma
Akula, Sm; Abrams, Sl; Steelman, Ls; Emma, Mr; Augello, G; Cusimano, A; Azzolina, A; Montalto, G; Cervello, M; Mccubrey, Ja
EXPERT OPINION ON THERAPEUTIC TARGETS
IF WOS: 5.473 SJR: 1.699 Best Quartile: Q1
Posizione: 7/10

Targeting HSP90 with the small molecule inhibitor AUY922 (luminespib) as a treatment strategy against hepatocellular carcinoma
Augello, G; Emma, Mr; Cusimano, A; Azzolina, A; Mongiovi, S; Puleio, R; Cassata, G; Gulino, A; Belmonte, B; Gramignoli, R; et al.
INTERNATIONAL JOURNAL OF CANCER
IF WOS: 5.145 SJR: 2.154 Best Quartile: Q1
Posizione: 4/14